Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S

180 L. Ed. 2d 884, 131 S. Ct. 3057, 564 U.S. 1035, 2011 U.S. LEXIS 4901, 79 U.S.L.W. 3727
Supreme Court of the United States·Decided June 27, 2011·No. No. 10-844·Published·Cited by 4 cases

Opinion

Petition for writ of cer-tiorari to the United States Court of Appeals for the Federal Circuit granted.

Same case below, 601 F.3d 1359.

Free access — add to your briefcase to read the full text and ask questions with AI

Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S, 180 L. Ed. 2d 884, 131 S. Ct. 3057, 564 U.S. 1035, 2011 U.S. LEXIS 4901, 79 U.S.L.W. 3727 (U.S. 2011).

180 L. Ed. 2d 884 (Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States ex rel. Bibby v. Wells Fargo Bank, N.A.
76 F. Supp. 3d 1399 (N.D. Georgia, 2015)
Dimm v. R.J. Reynolds Tobacco Co.
186 So. 3d 680 (Louisiana Court of Appeal, 2013)
Wood v. Montana Department of Revenue
826 F. Supp. 2d 1232 (D. Montana, 2011)
De Csepel v. Republic of Hungary
808 F. Supp. 2d 113 (District of Columbia, 2011)